Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.7 - $7.62 $972,000 - $2.74 Million
-360,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.3 - $8.84 $1.2 Million - $1.68 Million
-190,000 Reduced 34.55%
360,000 $2.56 Million
Q4 2021

Feb 14, 2022

BUY
$6.02 - $11.43 $3.31 Million - $6.29 Million
550,000 New
550,000 $4.58 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $119M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Soviero Asset Management, LP Portfolio

Follow Soviero Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soviero Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Soviero Asset Management, LP with notifications on news.